Member Sign In

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

Humana's (HUM) Q3 Earnings, Revenue Beat EstimatesNovember 04, 2016

Humana Inc. (HUM - Free Report) is one of the largest health care plan providers in the United States. The company’s takeover by Aetna Inc. is a much-awaited and closely watched event in the health insurance space. The acquisition is due in the second half of 2016. The agreement has been unanimously approved by the board of directors of both companies. The combined entity is expected to be the second-largest managed care company in the U.S.

At present Humana’s core operations include the provision of health insurance benefits under Health Maintenance Organization (HMO), Private Fee-For-Service (PFFS), and Preferred Provider Organization (PPO) plans. The company also provides other benefits with specialty products including dental, vision, and other supplementary benefits. Humana capitalizes on its established Accountable Care arrangement to provide its Medicare Advantage (MA) members with quality care at an affordable price.

Cash flows from operations totaled $1.47 billion, which compared favorably to cash flow from operations of $1 billion in the year ago quarter.

The company raised its 2016 adjusted EPS guidance to at least $9.50.

Check back later for our full write up on this HUM earnings report later!

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand.Click to see them now>>

Resources

Client Support

Follow Us

Zacks Research is Reported On:

Yahoo

MSN

Marketwatch

Nasdaq

Forbes

Investors.com

Morningstar

Zacks Investment Research is an A+ Rated BBB Accredited Business.

Copyright 2016 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1988-2015 and were examined and attested by Baker Tilly Virchow Krause, LLP, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.